Study of Bilateral Rhomboid Intercostal Block to Improve Pain Relief After Elective Bilateral Breast Implant Surgery

What this Trial Is About

This research aims to evaluate the effectiveness of bilateral Rhomboid Intercostal Block RIB for pain relief after elective bilateral breast prosthesis surgery. The study focuses on how this block might improve postoperative pain management and reduce the need for opioid pain medications. Eligible female patients aged 18 to 65 years with good physical health ASA status I-II will participate in this randomized, single-center trial. Participants will be randomly assigned to one of two groups. One group will receive an ultrasound-guided bilateral RIB block with a local anesthetic mixture before surgery, in addition to standard general anesthesia. The other group will undergo surgery with only standard general anesthesia and no regional block. All patients will receive postoperative pain control with intravenous tramadol administered by patient-controlled analgesia PCA. During the 24 hours after surgery, researchers will monitor total tramadol use, pain scores at specific time points, time to first pain medication request, need for additional pain relief, nausea and vomiting occurrence, and any complications related to the block. Assessments will be made at 0, 1, 2, 6, 12, and 24 hours postoperatively to understand the pain control effectiveness and safety of the RIB procedure.

Effect of Bilateral Rhomboid Intercostal Block on Postoperative Pain After Breast Implant Surgery